On January 14, 2013, Dr. Christopher McGuigan was appointed as a Director of TrovaGene, Inc. to serve until the next election of directors by the stockholders and until the election and qualification of his successor. Dr. McGuigan was nominated for the position by the Corporate Governance/Nominating Committee of the Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.25 USD | +8.17% |
|
-3.43% | +52.03% |
Jul. 01 | Cardiff Oncology, Inc.(NasdaqCM:CRDF) added to Russell Small Cap Comp Value Index | CI |
Jul. 01 | Cardiff Oncology, Inc.(NasdaqCM:CRDF) added to Russell Small Cap Completeness Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.03% | 101M | |
+16.59% | 44.44B | |
+42.49% | 40.03B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.29B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- CRDF Stock
- News Cardiff Oncology, Inc.
- TrovaGene, Inc. Appoints Christopher Mcguigan as Director